
    
      To evaluate the role of pain modulation in gastroesophageal reflux disease(GERD)patients who
      fail to obtain clinical relief with standard dose (once daily) proton pump inhibitor(PPI).
      The study will compare the efficacy; of 1)standard dose PPI plus low-dose tricyclic
      antidepressant (TCA) to, 2) double dose PPI to, 3) standard dose PPI and placebo to determine
      the relative symptom resolution and health related quality of life in GERD patients who fail
      standard dose PPI and are randomly assigned to one of these three groups.
    
  